Vaccinium sect. Cyanococcus
Vaccinium sect. Cyanococcus
Vaccinium sect. Cyanococcus encompasses a variety of blueberry species native to North America and Europe. While traditionally used in various culinary preparations, there are no specific traditional medicinal uses recorded for this plant. Scientific research has primarily focused on the molecular biology and genetic aspects of these plants, such as identifying microRNAs involved in fruit development and ripening. Additionally, studies have explored the potential health benefits, including antioxidant and cytotoxic effects against lung cancer cells, though more extensive clinical trials are needed to confirm these findings. Safety profiles indicate no major issues; however, comprehensive drug interaction data is currently unavailable, suggesting that interactions with medications are not a concern based on current knowledge.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- This study identified both conserved and novel microRNAs in blueberries, providing insights into their potential roles in fruit development and ripening.
- Blueberry extract showed antioxidant activities and inhibited A549 cell growth, suggesting potential anticancer activity.
- Adventitious shoot induction was more effective than axillary shoot induction for recovering solid polyploid shoots from chimeric Southern Highbush Blueberry lines.
- The study identified six species of Colletotrichum within the C. acutatum complex infecting various host plants in Korea, with some new pathogen-host combinations reported.
Frequently asked questions
What is Vaccinium sect. Cyanococcus?
Vaccinium sect. Cyanococcus (Vaccinium sect. Cyanococcus) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Vaccinium sect. Cyanococcus?
4 sourced findings are recorded for Vaccinium sect. Cyanococcus; the strongest carries evidence grade D. For example: This study identified both conserved and novel microRNAs in blueberries, providing insights into their potential roles in fruit development and ripening.
How strong is the evidence for Vaccinium sect. Cyanococcus?
The strongest finding for Vaccinium sect. Cyanococcus carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Vaccinium sect. Cyanococcus safe? What are the side effects?
No major safety issues are recorded for Vaccinium sect. Cyanococcus in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Vaccinium sect. Cyanococcus interact with medications?
No drug interactions are recorded for Vaccinium sect. Cyanococcus in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Vaccinium sect. Cyanococcus?
Vaccinium sect. Cyanococcus is also known as: голубика.
Is Vaccinium sect. Cyanococcus a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Identification of Conserved and Novel MicroRNAs in Blueberry. literature abstract metadata
- T2 Re-identification of Colletotrichum acutatum Species Complex in Korea and Their Host Plants. literature abstract metadata
- T2 Blueberry extract and its bioactive compounds mitigate oxidative stress and suppress human lung cancer cell (A549) growth by modulating the expression of p53/EGFR/STAT3/IL6-mediated signaling molecules. literature abstract metadata
- T2 Leaf Organogenesis Improves Recovery of Solid Polyploid Shoots from Chimeric Southern Highbush Blueberry. literature abstract metadata